|

CORT108297 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Johns Hopkins University1

Indications

  • Alzheimer's Disease1
  • Memory Impairment1
  • Mild Cognitive Impairment1
  • Alzheimer Disease1

Baltimore, Maryland1 trial

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

Johns Hopkins School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.